InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Cingulate Inc.

CING Clue Score34
United States Fiscal year ends December CIK 0001862150 Results filed 13 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

44
Insider
Date
Role
Action
Shares
Price
Amount
Thomas Jeffrey Hargroves
13 Feb 2026
Director
Buy indirect
97,276
$5.04
$490.27K
Matthew Brams
6 Feb 2026
EVP and Chief Medical Officer
Buy
1,946
$5.04
$9.81K
Shane J. Schaffer
6 Feb 2026
Chief Executive Officer
Buy indirect
6,809
$5.04
$34.32K
Jennifer L. Callahan
6 Feb 2026
SVP and CFO
Buy
4,864
$5.04
$24.51K
Peter J. Werth
6 Feb 2026
Director
Buy indirect
19,455
$5.04
$98.05K
Jennifer L. Callahan
15 Sep 2023
Corporate Controller
Buy
5,000
$0.67
$3.35K
Peter J. Werth
11 Aug 2023
Director
Buy indirect
1,823,155
$0.55
$1.00M
Jennifer L. Callahan
15 May 2023
Corporate Controller
Buy
2,000
$1.01
$2.02K
Jennifer L. Callahan
12 May 2023
Corporate Controller
Buy
4,000
$1.08
$4.32K
Shane J. Schaffer
16 Dec 2022
Chief Executive Officer
Buy
10,000
$1.02
$10.17K
Jennifer L. Callahan
14 Dec 2022
Corporate Controller
Buy
7,548
$0.99
$7.47K
Shane J. Schaffer
14 Dec 2022
Chief Executive Officer
Buy
13,267
$1.01
$13.40K
Shane J. Schaffer
13 Dec 2022
Chief Executive Officer
Buy
1,733
$1.01
$1.75K
Peter J. Werth
13 Dec 2022
Director
Buy indirect
28,934
$0.98
$28.42K
Jennifer L. Callahan
29 Nov 2022
Corporate Controller
Buy
1,530
$0.98
$1.50K
Jennifer L. Callahan
28 Nov 2022
Corporate Controller
Buy
3,487
$0.98
$3.42K
Craig S. Gilgallon
23 Nov 2022
EVP, GC and Secretary
Buy
3,575
$0.84
$3.00K
Laurie Myers
23 Nov 2022
EVP and COO
Buy
1,111
$0.90
$999.68
Gregg Wm Givens
22 Nov 2022
Director
Buy
85,000
$0.88
$74.85K
Jennifer L. Callahan
8 Sep 2022
Corporate Controller
Buy
3,500
$1.50
$5.25K
Peter J. Werth
6 Sep 2022
Director
Buy indirect
74,500
$1.52
$113.23K
Laurie Myers
1 Sep 2022
EVP and COO
Buy
636
$1.57
$999.47
Laurie Myers
1 Jun 2022
EVP and COO
Buy
200
$1.18
$236.38
Laurie Myers
17 May 2022
EVP and COO
Buy
200
$1.21
$241.58
Peter J. Werth
17 Mar 2022
Director
Buy indirect
27,000
$1.79
$48.33K
Jennifer L. Callahan
16 Mar 2022
Corporate Controller
Buy
1,900
$1.39
$2.64K
Laurie Myers
16 Mar 2022
EVP and COO
Buy
353
$1.40
$494.13
Gregg Wm Givens
15 Mar 2022
Director
Buy indirect
4,000
$1.38
$5.52K
Gregg Wm Givens
15 Mar 2022
Director
Buy indirect
4,000
$1.37
$5.48K
Gregg Wm Givens
15 Mar 2022
Director
Buy indirect
4,000
$1.37
$5.49K
Gregg Wm Givens
15 Mar 2022
Director
Buy
27,000
$1.38
$37.34K
Jennifer L. Callahan
15 Mar 2022
SVP and CFO
Buy
55
$27.10
$1.49K
Curtis Medeiros
14 Mar 2022
Director
Buy
17,532
$1.41
$24.76K
Gregg Wm Givens
14 Mar 2022
Director
Buy indirect
6,000
$1.29
$7.72K
Gregg Wm Givens
14 Mar 2022
Director
Buy indirect
6,000
$1.30
$7.79K
Gregg Wm Givens
14 Mar 2022
Director
Buy indirect
6,000
$1.30
$7.78K
Gregg Wm Givens
14 Mar 2022
Director
Buy
9,000
$1.32
$11.87K
Craig S. Gilgallon
14 Mar 2022
EVP & General Counsel
Buy
5,975
$1.38
$8.23K
Horn Louis G Van
14 Mar 2022
EVP and CFO
Buy
15,000
$1.34
$20.04K
Jennifer L. Callahan
14 Mar 2022
Corporate Controller
Buy
12,000
$1.46
$17.49K
Peter J. Werth
10 Dec 2021
Director
Buy indirect
8,300
—
no price
Shane J. Schaffer
10 Dec 2021
Chief Executive Officer
Buy
16,500
—
no price
Thomas Jeffrey Hargroves
10 Dec 2021
Director
Buy
8,300
—
no price
Gregg Wm Givens
10 Dec 2021
Director
Buy
16,500
—
no price
Show all 48 transactions →

What was left out

Form 4 filings counted 152
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 2
Transactions with no price 4
Shares from compensation/vesting 1,087,251
Sales filed before the plan box existed 1
History held since 9 Dec 2021